☰

Timothy W Corson - Publications

Affiliations: 
Indiana University School of Medicine, Indianapolis, IN, United States 
Area:
ophthalmology, angiogenesis, chemical biology, cancer
Tree Info Similar researchers PubMed Report error

72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Muniyandi A, Hartman GD, Song Y, Mijit M, Kelley MR, Corson TW. . The Journal of Pharmacology and Experimental Therapeutics. PMID 37142441 DOI: 10.1124/jpet.122.001563  0.332
2023 Nassief SM, Amer ME, Shawky E, Sishtla K, Mas-Claret E, Muniyandi A, Corson TW, Mulholland DA, El-Masry S. Antiangiogenic Pterocarpan and Flavonoid Constituents of . Journal of Natural Products. PMID 36938984 DOI: 10.1021/acs.jnatprod.2c00909  0.341
2023 Muniyandi A, Martin M, Sishtla K, Motolani A, Sun M, Jensen NR, Qi X, Boulton ME, Prabhu L, Lu T, Corson TW. PRMT5 is a therapeutic target in choroidal neovascularization. Scientific Reports. 13: 1747. PMID 36720900 DOI: 10.1038/s41598-023-28215-w  0.399
2022 Park B, Sardar Pasha SPB, Sishtla KL, Hartman GD, Qi X, Boulton ME, Corson TW. Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization. International Journal of Molecular Sciences. 23. PMID 36555236 DOI: 10.3390/ijms232415595  0.349
2022 Sishtla K, Lambert-Cheatham N, Lee B, Han DH, Park J, Sardar Pasha SPB, Lee S, Kwon S, Muniyandi A, Park B, Odell N, Waller S, Park IY, Lee SJ, Seo SY, ... Corson TW, et al. Small-molecule inhibitors of ferrochelatase are antiangiogenic agents. Cell Chemical Biology. PMID 35090600 DOI: 10.1016/j.chembiol.2022.01.001  0.312
2021 Hartman GD, Lambert-Cheatham NA, Kelley MR, Corson TW. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy. International Journal of Molecular Sciences. 22. PMID 34638620 DOI: 10.3390/ijms221910279  0.36
2021 Jacobs B, Palmer N, Shetty T, Dimaras H, Hajrasouliha A, Jusufbegovic D, Corson TW. Patient preferences in retinal drug delivery. Scientific Reports. 11: 18996. PMID 34556761 DOI: 10.1038/s41598-021-98568-7  0.778
2021 Heisel C, Yousif J, Mijiti M, Charizanis K, Brigell M, Corson TW, Kelley MR. APE1/Ref-1 as a Novel Target for Retinal Diseases. Journal of Cellular Signaling. 2: 133-138. PMID 34322687 DOI: 10.33696/Signaling.2.044  0.315
2021 Shetty T, Park B, Corson TW. Measurement of mitochondrial respiration in the murine retina using a Seahorse extracellular flux analyzer. Star Protocols. 2: 100533. PMID 34027490 DOI: 10.1016/j.xpro.2021.100533  0.758
2021 Sardar Pasha SPB, Shetty T, Lambert-Cheatham NA, Sishtla K, Mathew D, Muniyandi A, Patwari N, Bhatwadekar AD, Corson TW. Retinal Phenotyping of Ferrochelatase Mutant Mice Reveals Protoporphyrin Accumulation and Reduced Neovascular Response. Investigative Ophthalmology & Visual Science. 62: 36. PMID 33620374 DOI: 10.1167/iovs.62.2.36  0.784
2021 Shetty T, Park B, Corson TW. Measurement of mitochondrial respiration in the murine retina using a Seahorse extracellular flux analyzer Star Protocols. 2: 100533. DOI: 10.1016/j.xpro.2021.100533  0.749
2020 Doud EH, Shetty T, Abt M, Mosley AL, Corson TW, Mehta A, Yeh ES. NF-κB Signaling Is Regulated by Fucosylation in Metastatic Breast Cancer Cells. Biomedicines. 8. PMID 33322811 DOI: 10.3390/biomedicines8120600  0.766
2020 Shetty T, Corson TW. Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases. Frontiers in Pharmacology. 11: 1015. PMID 32760270 DOI: 10.3389/Fphar.2020.01015  0.783
2020 Shetty T, Sishtla K, Park B, Repass MJ, Corson TW. Heme Synthesis Inhibition Blocks Angiogenesis via Mitochondrial Dysfunction. Iscience. 23: 101391. PMID 32755804 DOI: 10.1016/J.Isci.2020.101391  0.796
2020 Barry Z, Park B, Corson TW. Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization. Molecules (Basel, Switzerland). 25. PMID 32751576 DOI: 10.3390/Molecules25153468  0.416
2020 Pran Babu SPS, White D, Corson TW. Ferrochelatase regulates retinal neovascularization. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32716567 DOI: 10.1096/Fj.202000964R  0.481
2020 Xu D, Zhou D, Bum-Erdene K, Bailey BJ, Sishtla K, Liu S, Wan J, Aryal UK, Lee JA, Wells CD, Fishel ML, Corson TW, Pollok K, Meroueh SO. Phenotypic Screening of Chemical Libraries Enriched by Molecular Docking to Multiple Targets Selected from Glioblastoma Genomic Data. Acs Chemical Biology. PMID 32243127 DOI: 10.1021/Acschembio.0C00078  0.401
2020 Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, Adio A, Afshar AR, Aggarwal P, Aghaji AE, Ahmad A, Akib MNR, Al Harby L, Al Ani MH, ... ... Corson TW, et al. Global Retinoblastoma Presentation and Analysis by National Income Level. Jama Oncology. PMID 32105305 DOI: 10.1001/Jamaoncol.2019.6716  0.498
2020 Merrigan SL, Park B, Ali Z, Jensen LD, Corson TW, Kennedy BN. Calcitriol and non-calcemic vitamin D analogue, 22-oxacalcitriol, attenuate developmental and pathological choroidal vasculature angiogenesis and . Oncotarget. 11: 493-509. PMID 32082484 DOI: 10.18632/Oncotarget.27380  0.356
2020 Whitmore H, Sishtla K, Knirsch W, Andriantiana JL, Schwikkard S, Mas-Claret E, Nassief SM, Isyaka SM, Corson TW, Mulholland DA. Bufadienolides and anti-angiogenic homoisoflavonoids from Rhodocodon cryptopodus, Rhodocodon rotundus and Rhodocodon cyathiformis. Fitoterapia. 104479. PMID 31927011 DOI: 10.1016/J.Fitote.2020.104479  0.776
2019 Heo M, Lee B, Sishtla K, Fei X, Lee S, Park S, Yuan Y, Lee S, Kwon S, Lee J, Kim S, Corson TW, Seo SY. Enantioselective Synthesis of Homoisoflavanones by Asymmetric Transfer Hydrogenation and Their Biological Evaluation for Antiangiogenic Activity. The Journal of Organic Chemistry. PMID 31381339 DOI: 10.1021/Acs.Joc.9B01134  0.436
2019 Seo SY, Corson TW. Small molecule target identification using photo-affinity chromatography. Methods in Enzymology. 622: 347-374. PMID 31155061 DOI: 10.1016/Bs.Mie.2019.02.028  0.31
2019 Schwikkard S, Whitmore H, Sishtla K, Sulaiman RS, Shetty T, Basavarajappa HD, Waller C, Alqahtani A, Frankemoelle L, Chapman A, Crouch N, Wetschnig W, Knirsch W, Andriantiana J, Mas-Claret E, ... ... Corson TW, et al. The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae ( sensu APGII). Journal of Natural Products. PMID 30951308 DOI: 10.1021/Acs.Jnatprod.8B00989  0.763
2019 Park B, Corson TW. Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future. Frontiers in Pharmacology. 10: 95. PMID 30792659 DOI: 10.3389/Fphar.2019.00095  0.419
2019 Waller S, Pasha SPBS, Lambert-Cheatham N, Corson TW. A novel ferrochelatase inhibitor as a therapy for ocular neovascularization Proceedings of Imprs. 2. DOI: 10.18060/23620  0.347
2018 Bum-Erdene K, Zhou D, Gonzalez-Gutierrez G, Ghozayel MK, Si Y, Xu D, Shannon HE, Bailey BJ, Corson TW, Pollok KE, Wells CD, Meroueh SO. Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction. Cell Chemical Biology. PMID 30581134 DOI: 10.1016/J.Chembiol.2018.11.010  0.348
2018 Zhou D, Bum-Erdene K, Xu D, Liu D, Tompkins D, Sulaiman RS, Corson TW, Chirgwin JM, Meroueh SO. Small molecules inhibit ex vivo tumor growth in bone. Bioorganic & Medicinal Chemistry. PMID 30470597 DOI: 10.1016/J.Bmc.2018.11.025  0.76
2018 Sishtla K, Pitt N, Shadmand M, O'Hare MN, Sulaiman RS, Sinn AL, Condon K, Pollok KE, Sandusky GE, Corson TW. Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14. Scientific Reports. 8: 16152. PMID 30385851 DOI: 10.1038/S41598-018-34603-4  0.767
2018 Sardar Pasha SPB, Sishtla K, Sulaiman RS, Park B, Shetty T, Shah F, Fishel ML, Wikel JH, Kelley MR, Corson TW. Ref-1/APE1 inhibition with novel small molecules blocks ocular neovascularization. The Journal of Pharmacology and Experimental Therapeutics. PMID 30076264 DOI: 10.1124/Jpet.118.248088  0.804
2018 Schwikkard SL, Whitmore H, Corson TW, Sishtla K, Langat MK, Carew M, Mulholland DA. Antiangiogenic Activity and Cytotoxicity of Triterpenoids and Homoisoflavonoids from Massonia pustulata and Massonia bifolia. Planta Medica. PMID 29490386 DOI: 10.1055/A-0577-5322  0.793
2017 Sulaiman RS, Park B, Sheik Pran Babu SP, Si Y, Kharwadkar R, Mitter SK, Lee B, Sun W, Qi X, Boulton ME, Meroueh SO, Fei X, Seo SY, Corson TW. Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization. Acs Chemical Biology. PMID 29193961 DOI: 10.1021/Acschembio.7B00854  0.812
2017 Basavarajappa HD, Sulaiman RS, Qi X, Shetty T, Sheik Pran Babu S, Sishtla KL, Lee B, Quigley J, Alkhairy S, Briggs CM, Gupta K, Tang B, Shadmand M, Grant MB, Boulton ME, ... ... Corson TW, et al. Ferrochelatase is a therapeutic target for ocular neovascularization. Embo Molecular Medicine. PMID 28377496 DOI: 10.15252/Emmm.201606561  0.786
2017 Pitt N, Sishtla K, Shadmand M, Sulaiman R, Sinn AL, Condon K, Sandusky GE, Corson TW. Abstract 2814: Effect of kif14 overexpression on tumor formation in mice in a lifespan study Cancer Research. 77: 2814-2814. DOI: 10.1158/1538-7445.Am2017-2814  0.755
2016 Lee B, Sun W, Lee H, Basavarajappa H, Sulaiman RS, Sishtla K, Fei X, Corson TW, Seo SY. Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids. Bioorganic & Medicinal Chemistry Letters. PMID 27481561 DOI: 10.1016/J.Bmcl.2016.07.043  0.798
2016 Racher H, Soliman S, Argiropoulos B, Chan HS, Gallie BL, Perrier R, Matevski D, Rushlow D, Piovesan B, Shaikh F, MacDonald H, Corson TW. Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma. Cancer Genetics. PMID 27318443 DOI: 10.1016/J.Cancergen.2016.06.001  0.551
2016 O'Hare M, Shadmand M, Sulaiman RS, Sishtla K, Sakisaka T, Corson TW. Kif14 overexpression accelerates murine retinoblastoma development. International Journal of Cancer. PMID 27270502 DOI: 10.1002/Ijc.30221  0.772
2016 Sulaiman RS, Merrigan S, Quigley J, Qi X, Lee B, Boulton ME, Kennedy B, Seo SY, Corson TW. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy. Scientific Reports. 6: 25509. PMID 27148944 DOI: 10.1038/Srep25509  0.816
2016 Corson TW, Dimaras H. The Molecular Genetics of Retinoblastoma Reviews in Cell Biology and Molecular Medicine. 2: 105-142. DOI: 10.1002/3527600906.Mcb.200400098.Pub2  0.35
2015 Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, Gallie BL. Retinoblastoma. Nature Reviews. Disease Primers. 1: 15021. PMID 27189421 DOI: 10.1038/nrdp.2015.21  0.548
2015 Sulaiman RS, Quigley J, Qi X, O'Hare MN, Grant MB, Boulton ME, Corson TW. A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. PMID 26060878 DOI: 10.1089/Jop.2015.0049  0.752
2015 Basavarajappa HD, Lee B, Lee H, Sulaiman RS, An H, Magaña C, Shadmand M, Vayl A, Rajashekhar G, Kim EY, Suh YG, Lee K, Seo SY, Corson TW. Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization. Journal of Medicinal Chemistry. 58: 5015-27. PMID 26035340 DOI: 10.1021/Acs.Jmedchem.5B00449  0.81
2015 Corson T, Racher H, Argiropoulos B, Chan H, Perrier R, Matevski D, Rushlow D, Shaikh F, Trang H, Gallie B. MG-127 Residual disease monitoring in a retinoblastoma patient by pcr of a novel deletion breakpoint Journal of Medical Genetics. 52: A10.2-A10. DOI: 10.1136/Jmedgenet-2015-103578.27  0.484
2014 Sulaiman RS, Basavarajappa HD, Corson TW. Natural product inhibitors of ocular angiogenesis. Experimental Eye Research. 129: 161-71. PMID 25304218 DOI: 10.1016/J.Exer.2014.10.002  0.798
2014 Lee B, Basavarajappa HD, Sulaiman RS, Fei X, Seo SY, Corson TW. The first synthesis of the antiangiogenic homoisoflavanone, cremastranone. Organic & Biomolecular Chemistry. 12: 7673-7. PMID 25167470 DOI: 10.1039/C4Ob01604A  0.803
2014 Luo N, Conwell MD, Chen X, Kettenhofen CI, Westlake CJ, Cantor LB, Wells CD, Weinreb RN, Corson TW, Spandau DF, Joos KM, Iomini C, Obukhov AG, Sun Y. Primary cilia signaling mediates intraocular pressure sensation. Proceedings of the National Academy of Sciences of the United States of America. 111: 12871-6. PMID 25143588 DOI: 10.1073/Pnas.1323292111  0.3
2014 Corson TW, Samuels BC, Wenzel AA, Geary AJ, Riley AA, McCarthy BP, Hanenberg H, Bailey BJ, Rogers PI, Pollok KE, Rajashekhar G, Territo PR. Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and development. Plos One. 9: e99036. PMID 24901248 DOI: 10.1371/Journal.Pone.0099036  0.374
2014 Singel SM, Cornelius C, Zaganjor E, Batten K, Sarode VR, Buckley DL, Peng Y, John GB, Li HC, Sadeghi N, Wright WE, Lum L, Corson TW, Shay JW. KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer. Neoplasia (New York, N.Y.). 16: 247-56, 256.e2. PMID 24784001 DOI: 10.1016/J.Neo.2014.03.008  0.595
2014 Basavarajappa HD, Lee B, Fei X, Lim D, Callaghan B, Mund JA, Case J, Rajashekhar G, Seo SY, Corson TW. Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth. Plos One. 9: e95694. PMID 24752613 DOI: 10.1371/Journal.Pone.0095694  0.813
2014 Thériault BL, Basavarajappa HD, Lim H, Pajovic S, Gallie BL, Corson TW. Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer. Plos One. 9: e91540. PMID 24626475 DOI: 10.1371/Journal.Pone.0091540  0.777
2014 Thériault BL, Dimaras H, Gallie BL, Corson TW. The genomic landscape of retinoblastoma: a review. Clinical & Experimental Ophthalmology. 42: 33-52. PMID 24433356 DOI: 10.1111/Ceo.12132  0.532
2013 Hines J, Gough JD, Corson TW, Crews CM. Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs. Proceedings of the National Academy of Sciences of the United States of America. 110: 8942-7. PMID 23674677 DOI: 10.1073/Pnas.1217206110  0.523
2013 Rushlow DE, Mol BM, Kennett JY, Yee S, Pajovic S, Thériault BL, Prigoda-Lee NL, Spencer C, Dimaras H, Corson TW, Pang R, Massey C, Godbout R, Jiang Z, Zacksenhaus E, et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. The Lancet. Oncology. 14: 327-34. PMID 23498719 DOI: 10.1016/S1470-2045(13)70045-7  0.537
2012 Basavarajappa HD, Corson TW. KIF14 as an oncogene in retinoblastoma: a target for novel therapeutics? Future Medicinal Chemistry. 4: 2149-52. PMID 23190103 DOI: 10.4155/Fmc.12.158  0.758
2012 Temming P, Corson TW, Lohmann DR. Retinoblastoma tumorigenesis: genetic and epigenetic changes walk hand in hand. Future Oncology (London, England). 8: 525-8. PMID 22646767 DOI: 10.2217/Fon.12.41  0.302
2012 Corson TW, Pajovic S, Dimaras H, Thériault BL, Gallie BL. Author response: Does the time of inactivation of pRb determine the cell of origin of retinoblastoma? Investigative Ophthalmology & Visual Science. 53: 676. PMID 22331504 DOI: 10.1167/Iovs.11-9371  0.515
2011 Pajovic S, Corson TW, Spencer C, Dimaras H, Orlic-Milacic M, Marchong MN, To KH, Thériault B, Auspitz M, Gallie BL. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties. Investigative Ophthalmology & Visual Science. 52: 7618-24. PMID 21862643 DOI: 10.1167/Iovs.11-7989  0.583
2011 Neklesa TK, Tae HS, Schneekloth AR, Stulberg MJ, Corson TW, Sundberg TB, Raina K, Holley SA, Crews CM. Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins. Nature Chemical Biology. 7: 538-43. PMID 21725302 DOI: 10.1038/Nchembio.597  0.748
2011 Corson TW, Cavga H, Aberle N, Crews CM. Triptolide directly inhibits dCTP pyrophosphatase. Chembiochem : a European Journal of Chemical Biology. 12: 1767-73. PMID 21671327 DOI: 10.1002/Cbic.201100007  0.582
2011 Buckley DL, Corson TW, Aberle N, Crews CM. HIV protease-mediated activation of sterically capped proteasome inhibitors and substrates. Journal of the American Chemical Society. 133: 698-700. PMID 21186803 DOI: 10.1021/Ja109377P  0.667
2008 Corson TW, Aberle N, Crews CM. Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One. Acs Chemical Biology. 3: 677-692. PMID 19112665 DOI: 10.1021/Cb8001792  0.556
2008 Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, Marrano P, Corson TW, Eagle RC, Squire JA, Gallie BL. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Human Molecular Genetics. 17: 1363-72. PMID 18211953 DOI: 10.1093/Hmg/Ddn024  0.558
2007 Huang JC, Babak T, Corson TW, Chua G, Khan S, Gallie BL, Hughes TR, Blencowe BJ, Frey BJ, Morris QD. Using expression profiling data to identify human microRNA targets. Nature Methods. 4: 1045-9. PMID 18026111 DOI: 10.1038/Nmeth1130  0.524
2007 Madhavan J, Coral K, Mallikarjuna K, Corson TW, Amit N, Khetan V, George R, Biswas J, Gallie BL, Kumaramanickavel G. High expression of KIF14 in retinoblastoma: association with older age at diagnosis. Investigative Ophthalmology & Visual Science. 48: 4901-6. PMID 17962437 DOI: 10.1167/Iovs.07-0063  0.553
2007 Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell. 130: 769-74. PMID 17803898 DOI: 10.1016/J.Cell.2007.08.021  0.536
2007 Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS, Gallie BL. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3229-34. PMID 17545527 DOI: 10.1158/1078-0432.Ccr-07-0393  0.517
2007 Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes, Chromosomes & Cancer. 46: 617-34. PMID 17437278 DOI: 10.1002/Gcc.20457  0.547
2007 Bowles E, Corson TW, Bayani J, Squire JA, Wong N, Lai PB, Gallie BL. Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes, Chromosomes & Cancer. 46: 118-29. PMID 17099872 DOI: 10.1002/Gcc.20383  0.543
2006 Corson TW, Gallie BL. KIF14 mRNA expression is a predictor of grade and outcome in breast cancer. International Journal of Cancer. 119: 1088-94. PMID 16570270 DOI: 10.1002/Ijc.21954  0.541
2005 Spencer C, Pajovic S, Devlin H, Dinh QD, Corson TW, Gallie BL. Distinct patterns of expression of the RB gene family in mouse and human retina. Gene Expression Patterns : Gep. 5: 687-94. PMID 15939381 DOI: 10.1016/J.Modgep.2005.02.003  0.585
2005 Corson TW, Huang A, Tsao MS, Gallie BL. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene. 24: 4741-53. PMID 15897902 DOI: 10.1038/Sj.Onc.1208641  0.552
2004 Marchong MN, Chen D, Corson TW, Lee C, Harmandayan M, Bowles E, Chen N, Gallie BL. Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. Molecular Cancer Research : McR. 2: 495-503. PMID 15383628  0.514
2004 Corson TW, Woo KK, Li PP, Warsh JJ. Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 143-50. PMID 15013030 DOI: 10.1016/S0924-977X(03)00102-0  0.311
Show low-probability matches.